96726 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides with the first amino acid being basic
IGF-I poly (ethylene glycol) conjugates
#302Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide
#303REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF
#304Transglutaminase-activating peptide and cosmetic or pharmaceutical composition containing same
#305Oligopeptides And Their Use In Cosmetics
#306High penetration prodrug compositions of peptides and peptide-related compounds
#307METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE
#308Composition
#309Method of treating tumors
#310Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#311Scaffold-based polymerase enzyme substrates
#312Methods for assaying enzyme activities
#313Therapeutic and diagnostic conjugates for use with multispecific antibodies
#314Functionalized cyanine dyes (PEG)
#315Molecular adaptors for dye conjugates
#316Functionalized cyanine dyes (PEG)
#317Phospholinked dye analogs with an amino acid linker
#318Cyanine dyes
#319Substrate peptide sequences for plague plasminogen activator and uses thereof
#320Neuroprotective and neurorestorative method and compositions
#321Proteasome-activating anti-aging peptides and compositions containing same
#322Methods for preventing or treating mitochondrial permeability transition
#323G-TYPE PEPTIDES AND OTHER AGENTS TO AMELIORATE ATHEROSCLEROSIS AND OTHER PATHOLOGIES
#324Noggin-derived peptide and use thereof
#325Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp
#326Inhibiting tumor cell invasion, metastasis and angiogenesis
#327Vaccinia virus protein A46 peptide and use thereof
#328Oligomeric biosurfactants in dermatocosmetic compositions
#329POLYNUCLEOTIDES ENCODING PROMYOSTATIN POLYPEPTIDES
#330Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
#331BLOOD COAGULATION FACTOR INHIBITORS
#332Uses of kappa opioid synthetic peptide amides
#333Lymphatic zip codes in tumors and pre-malignant lesions
#334Methods and compositions for modulating hepatocyte growth factor activator
#335Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions
#336Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
#337Benzylic compound
#338Fluorine-labeled compounds
#339Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
#340ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF
#341METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#342Collagen peptide conjugates and uses therefor
#343Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails
#344PROTEIN VARIANTS HAVING MODIFIED IMMUNOGENICITY
#345Polypeptides KXK and their use
#346Blood coagulation factor inhibitors
#347Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
#348Methods for reducing CD36 expression
#349Compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
#350Methods for reducing oxidative damage
#351NOVEL PEPTIDES, USE THEREOF IN COSMETIC AND COSMECEUTIC APPLICATIONS, AND COMPOSITIONS COMPRISING SAME
#352Thienopyranones as kinase inhibitors
#353PEPTIDE GAP JUNCTION MODULATORS
#354Lipid peptide and hydrogel
#355POLYPEPTIDE
#356RGD-MODIFIED ALGINATE MICROPARTICLES AS A DRUG RELEASE SYSTEM
#357Antimicrobial compounds and formulations
#358Peptide derivatives and cosmetic composition comprising the same
#359Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
#360PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES
#361αβintegrin binding RGD-lipopeptides with gene transfer activities
#362PEPTIDES AND PEPTIDE MIMETICS TO TREAT CANCER
#363Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#364Modulation of activity of proneurotrophins
#365Method and carrier complexes for delivering molecules to cells
#366D-amino acid peptides
#367Mucin hypersecretion inhibitors and methods of use
#368METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#369Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
#370Antimicrobial and anticancer lipopeptides
#371Antimicrobial peptides
#372Polymeric biosurfactants
#373Oligopeptides and their use in cosmetics
#374Endothelium mimicking nanomatrix
#375CHOLESTEROL LOWERING PROTEIN HYDROLYSATES
#376METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF INFLUENZA
#377POLY(AMINO ACID) COMPOUND HAVING INHIBITORY ACTIVITY ON ABSORPTION OF PHOSPHORUS AND PHOSPHORUS ABSORPTION INHIBITOR
#378Peptides for the regulation of neurotransmitter sequestration and release
#379REGULATION OF APG8 PHOSPHORYLATION AND USES THEREOF
#380Regulation of autophagy pathway phosphorylation and uses thereof
#381PEPTIDE-BASED COMPOUNDS AS NEW INHIBITORS OF METALLOECTOPEPTIDASES, COMPOSITIONS COMPRISING SAID COMPOUNDS AND THEIR PHARMACEUTICAL AND COSMETIC USES
#382Peptides Inhibiting Angiotensin-Converting Enzyme
#383Production and use of novel peptide-based agents with bispecific antibodies
#384CHOLESTEROL LOWERING PROTEIN HYDROLYSATES
#385Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#386Mucin hypersecretion inhibitors and methods of use
#387Methods for reducing CD36 expression
#388Selective substrates for matrix metalloproteinases
#389Method for reducing the risk, lessening the symptom, or delaying the onset of insulin resistance by administering SS-31
#390Methods and compositions related to internalizing RGD peptides
#391Treatment methods using peptides related to amyloid precursor protein
#392Methods For Immuno-Detection Of Epitopes On Molecules And For Detection Of Interactions Of Molecules Via Fluorescent Dyes
#393Methods for prevention and treatment of acute renal injury
#394Fluorescent imaging agents
#395Neuropeptides and their use for pest control
#396NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
#397Method for determining thermal stability of collagen or collagen-like peptide
#398Inhibiting tumor cell invasion, metastasis and angiogenesis
#399Peptide lipid-containing carrier and method for introducing compound into cells using same
#400Peptide inhibiting angiotensin converting enzyme
#401Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
#402PEPTIDES FOR USE IN CULTURE MEDIA
#403Peptide derivatives useful as antimicrobial agents and for treating wounds
#404POLYPEPTIDE
#405Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
#406Substrate peptide sequences for plague plasminogen activator and uses thereof
#407METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
#408Novel Polypeptide Ligands For Toll-Like Receptor 2 (TLR2)
#409Attractin/mahogany-like polypeptides
#410Polynucleotides encoding promyostatin polypeptides
#411Composite material useful as biomaterial and its preparation
#412Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors
#413Antibody Binding Affinity Ligands
#414Peptides based on the sequence of human lactoferrin and their use
#415C-Met receptor regulation by angiotensin IV (AT) receptor ligands
#416Peptides that antagonize FPR class receptor mediated signaling
#417METHODS OF MAKING AND USING SURFACTANT POLYMERS
#418Convergent Solid Phase Peptide Synthesis By Reaction Of Two Fragments Bound To Solid Support
#419Hiv Prodrugs Cleavable by Cd26
#420PHARMACEUTICAL COMPOSITIONS OF HYDROMORPHONE FOR PREVENTION OF OVERDOSE OR ABUSE
#421Synthetic peptides and methods of use for autoimmune disease therapies
#422Peptidomimetic agents from dextrorotatory amino acids as well as pharmaceutical agents that contain the latter for treatment of neurodegenerative diseases
#423Treatment methods using polypeptides related to amyloid precursor protein
#424Fluorine-labeled compounds
#425Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#426ABUSE-RESISTANT HYDROCODONE COMPOUNDS, COMPOSITIONS AND METHODS OF USING THE SAME
#427Prodrugs cleavable by CD26
#428Synthetic antimicrobial polypeptides
#429Collections of Traceable Compounds and Uses Thereof
#430Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
#431Lymphatic zip codes in tumors and pre-malignant lesions
#432Methods and compositions for diagnosis and treatment of influenza
#433Tetrapeptide regulating blood glucose level in diabetes mellitus
#434D-amino acid peptides
#435Methods for reducing CD36 expression
#436Histone H2A peptide derivatives and uses thereof
#437Peptides for enhanced cell attachment and growth
#438Antimicrobial and anticancer lipopeptides
#439Orally administered small peptides synergize statin activity
#440Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#441Methods for preventing or treating ischemia-reperfusion injury of the kidney
#442Orthogonally protected bifunctional amino acid
#443Polypeptide
#444Methods for reducing oxidative damage
#445Peptidic conjugates for alopecia prevention and treatment
#446Phex substrates and methods using same
#447Peptides promoting cell adherence, growth and secretion
#448Modified antiviral peptides with increased activity and cell membrane affinity
#449Method of designing physiologically active peptide and use thereof
#450G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
#451Intracellular delivery of biological effectors
#452Mucin hypersecretion inhibitors and methods of use
#453Intracellular delivery of biological effectors
#454Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#455Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
#456Peptides and methods for the control of obesity
#457Antimicrobial peptides with reduced hemolysis and methods of their use
#458Methods for accumulating arbitrary peptides in plant protein bodies
#459Peptides for use in culture media
#460Methods for reducing oxidative damage
#461Neurotrophic and neuroprotective peptides
#462Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
#463Production and use of novel peptide-based agents with bispecific antibodies
#464Alpha-4 beta-1 integrin ligands for imaging and therapy
#465Attenuation of metapneumovirus
#466Molecular interactions in cells
#467Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#468Synthetic antimicrobial polypeptides
#469Neuropeptides and their use for pest control
#470Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
#471Compositions and methods for determining substrate specificity of hydrolytic enzymes
#472Peptides for use in culture media
#473Selective substrates for matrix metalloproteinases
#474Protein variants having modified immunogenicity
#475Orally administered small peptides synergize statin activity
#476Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#477Methods and compositions for derepression of IAP-inhibited caspase
#478Method and carrier complexes for delivering molecules to cells
#479Anti-fibril peptides
#480Methods and compositions for derepression of IAP-inhibited caspase
#481Peptides for enhanced cell attachment and growth
#482Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#483D-amino acid peptides
#484Methods of making and using surfactant polymers
#485Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis
#486Therapeutic and diagnostic conjugates for use with multispecific antibodies